# Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

> **NCT07746271** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The George Washington University Biostatistics Center** · enrollment: 4120 (estimated)

## Conditions studied

- Hypertension in Pregnancy
- Obstetrical Complications

## Interventions

- **DRUG:** Anti-hypertensive medication titrated to a BP goal of <140/90 mmHg
- **OTHER:** Usual Care: Anti-hypertensive medication for BP ≥160/110 mmHg titrated to a goal of < 160/110 mmHg

## Key facts

- **NCT ID:** NCT07746271
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-04-30
- **Target enrollment:** 4120 (ESTIMATED)
- **Last updated:** 2026-09-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746271, "Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*